BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2024
09/30/2023
09/30/2022
09/30/2021
09/30/2020
Revenue
26
25
46
64
57
50
Revenue Growth (YoY)
-10%
-46%
-28%
12%
14%
9%
Cost of Revenue
21
20
44
58
51
42
Gross Profit
5
4
1
6
5
7
Selling, General & Admin
5
3
3
2
3
2
Research & Development
1
1
0
1
0
0
Operating Expenses
7
4
4
4
3
2
Other Non Operating Income (Expenses)
0
0
0
0
0
1
Pretax Income
-7
-2
-7
1
3
5
Income Tax Expense
-4
0
0
0
0
0
Net Income
-2
-1
-7
1
3
5
Net Income Growth
-71%
-86%
-800%
-67%
-40%
0%
Shares Outstanding (Diluted)
31.61
7.22
7.15
35.75
34.09
35
Shares Change (YoY)
342%
1%
-80%
5%
-3%
0%
EPS (Diluted)
-0.08
-0.19
-1.08
0.03
0.09
0.14
EPS Growth
-93%
-82%
-3,727%
-67%
-36%
-7%
Free Cash Flow
-6
0
-1
9
-3
4
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
19.23%
16%
2.17%
9.37%
8.77%
14%
Operating Margin
-7.69%
0%
-4.34%
3.12%
3.5%
8%
Profit Margin
-7.69%
-4%
-15.21%
1.56%
5.26%
10%
Free Cash Flow Margin
-23.07%
0%
-2.17%
14.06%
-5.26%
8%
EBITDA
-1
1
-1
3
3
5
EBITDA Margin
-3.84%
4%
-2.17%
4.68%
5.26%
10%
D&A For EBITDA
1
1
1
1
1
1
EBIT
-2
0
-2
2
2
4
EBIT Margin
-7.69%
0%
-4.34%
3.12%
3.5%
8%
Effective Tax Rate
57.14%
0%
0%
0%
0%
0%
Follow-Up Questions
What are BGM Group Ltd's key financial statements?
According to the latest financial statement (Form-10K), BGM Group Ltd has a total asset of $53, Net loss of $-1
What are the key financial ratios for BGM?
BGM Group Ltd's Current ratio is 5.3, has a Net margin is -4, sales per share of $3.45.
How is BGM Group Ltd's revenue broken down by segment or geography?
BGM Group Ltd largest revenue segment is Oxytetracycline & Licorice Products and Traditional Chinese Medicine Derivatives, at a revenue of 21,961,282 in the most earnings release.For geography, China is the primary market for BGM Group Ltd, at a revenue of 25,097,951.
Is BGM Group Ltd profitable?
no, according to the latest financial statements, BGM Group Ltd has a net loss of $-1